feed,title,long_url,short_url
Benzinga,Summary Rejection by Calfrac's Special Committee of Wilks' Superior Proposal Unfairly Disregards the Interests of All Stakeholders; Superior Proposal Will Remain Available to the Company if Shareholders Reject the Initial Management Transaction,https://www.benzinga.com/pressreleases/20/08/n17136238/summary-rejection-by-calfracs-special-committee-of-wilks-superior-proposal-unfairly-disregards-the,https://j.mp/2PZbUuy
Benzinga,"The Daily Biotech Pulse: Poseida's Phase 1 Study Placed On Clinical Hold, Orphan Drug Designation For Krystal Biotech, Tiziana's Patent Award",https://www.benzinga.com/general/biotech/20/08/17134669/the-daily-biotech-pulse-poseidas-phase-1-study-placed-on-clinical-hold-orphan-drug-designation-fo,https://j.mp/3aAhGMt
Benzinga,10 Biggest Price Target Changes For Tuesday,https://www.benzinga.com/markets/penny-stocks/20/08/17136191/10-biggest-price-target-changes-for-tuesday,https://j.mp/314hKRw
